Tobin Schilke
Chief Financial Officer · 2 filings · Latest: Mar 3, 2026
Crinetics Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
CRNX | Tobin Schilke | Chief Financial Officer | Mar 3, 2026 | Sale | $39.67 | 6,713 | $266.3K | 78,121 | |
CRNX | Tobin Schilke | — | Mar 2, 2026 | Proposed Sale | $41.18 | 6,800 | $280.0K | — | |